Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (91-100 of 442) with videos related to

Pageof 45
Sort By:
American Journal of Hematology|September 16, 2018
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMTMaximilian Christopeit, Myriam Labopin, Norbert-Claude Gorin, et al.
Blood|December 31, 2009
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant groupThomas Klingebiel, Jacqueline Cornish, Myriam Labopin, et al.
British Journal of Haematology|August 18, 2018
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Jonathan Canaani, Myriam Labopin, Xiao J Huang, et al.
Blood|February 24, 2016
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survivalFlorent Malard, Myriam Labopin, Patrice Chevallier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Francesco Frassoni, et al.
Cancer|February 18, 2017
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMTJiří Pavlů, Myriam Labopin, Anna K Zoellner, et al.
European Journal of Haematology|June 19, 2012
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMTPatrice Chevallier, Myriam Labopin, Stefanie Buchholz, et al.
Haematologica|February 1, 2015
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysisNorbert-Claude Gorin, Myriam Labopin, Simona Piemontese, et al.
Bone Marrow Transplantation|September 2, 2023
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMTArnon Nagler, Myriam Labopin, Nicolaus Kröger, et al.
Haematologica|May 13, 2008
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remissionLoic Fouillard, Myriam Labopin, Alois Gratwohl, et al.
Pageof 45

Showing results (91-100 of 442) with videos related to

Sort By:
Pageof 45
American Journal of Hematology|September 16, 2018
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMTMaximilian Christopeit, Myriam Labopin, Norbert-Claude Gorin, et al.
Blood|December 31, 2009
Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant groupThomas Klingebiel, Jacqueline Cornish, Myriam Labopin, et al.
British Journal of Haematology|August 18, 2018
Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)Jonathan Canaani, Myriam Labopin, Xiao J Huang, et al.
Blood|February 24, 2016
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survivalFlorent Malard, Myriam Labopin, Patrice Chevallier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2008
Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow TransplantationNorbert-Claude Gorin, Myriam Labopin, Francesco Frassoni, et al.
Cancer|February 18, 2017
Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMTJiří Pavlů, Myriam Labopin, Anna K Zoellner, et al.
European Journal of Haematology|June 19, 2012
Clofarabine-containing conditioning regimen for allo-SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMTPatrice Chevallier, Myriam Labopin, Stefanie Buchholz, et al.
Haematologica|February 1, 2015
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysisNorbert-Claude Gorin, Myriam Labopin, Simona Piemontese, et al.
Bone Marrow Transplantation|September 2, 2023
The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMTArnon Nagler, Myriam Labopin, Nicolaus Kröger, et al.
Haematologica|May 13, 2008
Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remissionLoic Fouillard, Myriam Labopin, Alois Gratwohl, et al.
Pageof 45